BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16825821)

  • 1. Association of Urokinase Gene 3'-UTR T/C polymorphism with bladder cancer.
    Manchanda PK; Bid HK; Mittal RD
    Urol Int; 2006; 77(1):81-4. PubMed ID: 16825821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder.
    Tsai FJ; Chang CH; Chen CC; Hsia TC; Chen HY; Chen WC
    BJU Int; 2005 Feb; 95(3):432-5. PubMed ID: 15679809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK; Manchanda PK; Mittal RD
    Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
    Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
    BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
    Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Gene mutations in superficial bladder cancer.
    Lorenzo Romero JG; Salinas Sánchez AS; Giménez Bachs JM; Sánchez Sánchez F; Escribano Martínez J; Hernández Millán IR; Segura Martín M; Virseda Rodríguez JA
    Urol Int; 2004; 73(3):212-8. PubMed ID: 15539839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase gene 3'-UTR T/C polymorphism is associated with oral cancer.
    Tsai MH; Chen WC; Chen HY; Tsai FJ
    J Clin Lab Anal; 2004; 18(5):276-9. PubMed ID: 15356878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.
    Srivastava DS; Mishra DK; Mandhani A; Mittal B; Kumar A; Mittal RD
    Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer.
    Wang SY; Peng L; Li CP; Li AP; Zhou JW; Zhang ZD; Liu QZ
    Int J Urol; 2008 Jun; 15(6):534-9. PubMed ID: 18422577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
    Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
    Tsai FJ; Lin CC; Lu HF; Chen HY; Chen WC
    Urology; 2002 Mar; 59(3):458-61. PubMed ID: 11880102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
    Srivastava DS; Kumar A; Mittal B; Mittal RD
    Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of urokinase gene 3'-UTR polymorphism with bronchopulmonary dysplasia for ventilated preterm infants.
    Lin HC; Su BH; Lin TW; Hsu CM; Wan L; Tsai CH; Tsai FJ
    Acta Paediatr Taiwan; 2004; 45(6):315-9. PubMed ID: 15868845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene.
    Sakano S; Berggren P; Kumar R; Steineck G; Adolfsson J; Onelöv E; Hemminki K; Larsson P
    Int J Cancer; 2003 Mar; 104(1):98-103. PubMed ID: 12532425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is urokinase gene 3'-UTR polymorphism associated with prostate cancer?
    Mittal RD; Srivastava DS; Mishra DK
    Cancer Biomark; 2005; 1(6):287-92. PubMed ID: 17192053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.